Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
HLA|June 5, 2024
Post-transplant de novo anti-HLA donor specific antibodies may contribute to poor graft function after haploidentical haematopoietic stem cell transplantationXinyu Ji, Luxin Yang, Xiaoyu Lai, et al.
Journal of Hematology & Oncology|April 8, 2020
Mechanisms and rejuvenation strategies for aged hematopoietic stem cellsXia Li, Xiangjun Zeng, Yulin Xu, et al.
Biochemical and Biophysical Research Communications|January 16, 2008
The E3 ubiquitin ligase HECTD3 regulates ubiquitination and degradation of TaraJian Yu, Jianping Lan, Yuanyuan Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2019
Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell TransplantationYanmin Zhao, Fei Gao, Jimin Shi, et al.
Molecular Medicine Reports|June 18, 2016
NR2F2 regulates bone marrow-derived mesenchymal stem cell-promoted proliferation of Reh cellsNi Zhu, Huafang Wang, Jieping Wei, et al.
Journal of Cheminformatics|February 11, 2025
FluoBase: a fluorinated agents databaseRafal Mulka, Dan Su, Wen-Shuo Huang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 21, 2020
A Novel Strategy for the Prevention of Hepatitis B Virus-Related Hepatitis Following Allogeneic Hematopoietic Stem Cell Transplantation from Hepatitis B Surface Antigen-Positive DonorsYibo Wu, Jimin Shi, Yamin Tan, et al.
Cancer Letters|November 11, 2009
PML3 interacts with TRF1 and is essential for ALT-associated PML bodies assembly in U2OS cellsJian Yu, Jianping Lan, Chong Wang, et al.
Cancer Reports (Hoboken, N.J.)|July 2, 2026
Salvage Therapy With Inotuzumab Ozogamicin in Relapsed/Refractory B-ALL After CAR-T Therapy and HSCT: A Case SeriesHonghu Li, Luxin Yang, Lizhen Liu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2020
Calcineurin Inhibitors Replacement by Ruxolitinib as Graft-versus-Host Disease Prophylaxis for Patients after Allogeneic Stem Cell TransplantationYanmin Zhao, Jimin Shi, Yi Luo, et al.
Pageof 11